financetom
Business
financetom
/
Business
/
--Capital One Securities Adjusts Expand Energy PT to $100 From $108, Maintains Overweight Rating
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Capital One Securities Adjusts Expand Energy PT to $100 From $108, Maintains Overweight Rating
Aug 27, 2025 9:57 AM

12:43 PM EDT, 08/27/2025 (MT Newswires) --

Price: 96.43, Change: +0.15, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aura Minerals to Delist From Toronto Stock Exchange
Aura Minerals to Delist From Toronto Stock Exchange
Aug 4, 2025
08:30 AM EDT, 08/04/2025 (MT Newswires) -- Aura Minerals ( AUGO ) said Monday it plans to voluntarily delist its common shares from the Toronto Stock Exchange, subject to approval from both the exchange and Brazil's securities regulator. The company said the move follows its recent listing on Nasdaq on July 16 and reflects its intention to consolidate trading on...
NYSE names Bryan Daniel as president of NYSE Texas
NYSE names Bryan Daniel as president of NYSE Texas
Aug 4, 2025
Aug 4 (Reuters) - The New York Stock Exchange said on Monday it has named Bryan Daniel, a former staffer of Texas Governor Greg Abbott, as the president of NYSE Texas. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Praxis Precision Medicines Says Vormatrigine Shows Seizure Reduction in Phase 2 Study; Shares Rise Pre-Bell
Praxis Precision Medicines Says Vormatrigine Shows Seizure Reduction in Phase 2 Study; Shares Rise Pre-Bell
Aug 4, 2025
08:36 AM EDT, 08/04/2025 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) said Monday its experimental drug vormatrigine reduced seizure frequency by a median of 56.3% in patients with focal onset seizures during an eight-week phase 2 trial. The company said the study showed that about 22% of patients treated with the drug candidate experienced a complete seizure-free period...
Copyright 2023-2026 - www.financetom.com All Rights Reserved